Genomics startup GeneCentric in Durham raises $7.5M for commercialization effort
GeneCentric Therapeutics has raised $7.5 million in a Series B1 round, the company announced today.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
